SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-083940
Filing Date
2020-07-16
Accepted
2020-07-16 08:34:34
Documents
6
Period of Report
2020-07-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023472-7_8k.htm 8-K 33103
2 EXHIBIT 1.1 tm2023472d7_ex1-1.htm EX-1.1 320752
3 EXHIBIT 5.1 tm2023472d7_ex5-1.htm EX-5.1 10013
4 GRAPHIC tm2023472d7_ex5-1img001.jpg GRAPHIC 5227
5 GRAPHIC tm2023472d7_ex1-1exaimg001.jpg GRAPHIC 348714
6 GRAPHIC tm2023472d7_ex1-1exaimg002.jpg GRAPHIC 473719
  Complete submission text file 0001104659-20-083940.txt   1505375
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38935 | Film No.: 201030809
SIC: 2834 Pharmaceutical Preparations